| NCT ID | NCT06210620 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Össur Iceland ehf |
| Condition | Amputation |
| Study Type | OBSERVATIONAL |
| Enrollment | 2,000 participants |
| Start Date | 2024-01-01 |
| Primary Completion | 2033-09 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 2,000 participants in total. It began in 2024-01-01 with a primary completion date of 2033-09.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
A national, multi-center registry of patients using lower-limb prosthesis, their profiles and devices, and their long-term follow-up and clinical outcomes.
Eligibility Criteria
Inclusion Criteria: Cognitive ability to understand all instructions and questionnaires in the study Willing and able to participate in the study and follow the protocol Individuals with lower limb loss, amputation or deficiency Exclusion Criteria: None
Frequently Asked Questions
Who can join the NCT06210620 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Amputation. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06210620 currently recruiting?
Yes, NCT06210620 is actively recruiting participants. Visit ClinicalTrials.gov or contact Össur Iceland ehf to inquire about joining.
Where is the NCT06210620 trial being conducted?
This trial is being conducted at Irvine, United States.
Who is sponsoring the NCT06210620 clinical trial?
NCT06210620 is sponsored by Össur Iceland ehf. The trial plans to enroll 2,000 participants.